Literature DB >> 22255820

Early detection and characterization of Alzheimer's disease in clinical scenarios using Bioprofile concepts and K-means.

Javier Escudero1, John P Zajicek, Emmanuel Ifeachor.   

Abstract

Alzheimer's Disease (AD) is the most common neurodegenerative disease in elderly people. There is a need for objective means to detect AD early to allow targeted interventions and to monitor response to treatment. To help clinicians in these tasks, we propose the creation of the Bioprofile of AD. A Bioprofile should reveal key patterns of a disease in the subject's biodata. We applied k-means clustering to data features taken from the ADNI database to divide the subjects into pathologic and non-pathologic groups in five clinical scenarios. The preliminary results confirm previous findings and show that there is an important AD pattern in the biodata of controls, AD, and Mild Cognitive Impairment (MCI) patients. Furthermore, the Bioprofile could help in the early detection of AD at the MCI stage since it divided the MCI subjects into groups with different rates of conversion to AD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22255820     DOI: 10.1109/IEMBS.2011.6091597

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  6 in total

1.  Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Authors:  Annie M Racine; Rebecca L Koscik; Sara E Berman; Christopher R Nicholas; Lindsay R Clark; Ozioma C Okonkwo; Howard A Rowley; Sanjay Asthana; Barbara B Bendlin; Kaj Blennow; Henrik Zetterberg; Carey E Gleason; Cynthia M Carlsson; Sterling C Johnson
Journal:  Brain       Date:  2016-06-20       Impact factor: 13.501

2.  Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis.

Authors:  Yangdi Peng; Bin Chen; Lifen Chi; Qiang Zhou; Zhenjing Shi
Journal:  Front Aging Neurosci       Date:  2020-10-06       Impact factor: 5.750

3.  Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).

Authors:  Paloma Bermejo-Bescós; Sagrario Martín-Aragón; Karim Jiménez-Aliaga; Juana Benedí; Emanuela Felici; Pedro Gil; José Manuel Ribera; Angel María Villar
Journal:  Neurochem Res       Date:  2013-04-11       Impact factor: 3.996

4.  Disentangling Heterogeneity in Alzheimer's Disease: Two Empirically-Derived Subtypes.

Authors:  Anna E Blanken; Shubir Dutt; Yanrong Li; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

5.  The Application of Unsupervised Clustering Methods to Alzheimer's Disease.

Authors:  Hany Alashwal; Mohamed El Halaby; Jacob J Crouse; Areeg Abdalla; Ahmed A Moustafa
Journal:  Front Comput Neurosci       Date:  2019-05-24       Impact factor: 2.380

6.  Applying Big Data Methods to Understanding Human Behavior and Health.

Authors:  Ahmed A Moustafa; Thierno M O Diallo; Nicola Amoroso; Nazar Zaki; Mubashir Hassan; Hany Alashwal
Journal:  Front Comput Neurosci       Date:  2018-10-16       Impact factor: 2.380

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.